Drug Trial Radar · NCT01299116
Long-Acting Reversible Contraception
Last checked: Nov 19, 2026Latest source record: Feb 28, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
916
Actual
Start
Dec 2011
Primary completion
Jun 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- FHI 360Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 18, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 29 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
In the proposed study, women aged 18-29 seeking oral or injectable contraception will be offered an opportunity to try LARC instead; the FDA-approved options include two types of intrauterine products and one type of subdermal contraceptive implant. Over a 24 month period, the experiences of LARC users will be compared to the experiences of those opting for their initial short-acting method.
Conditions
- Contraception
Interventions
DMPADrug
Injectable contraceptive, containing 150 mg depot medroxyprogesterone acetate (DMPA) and marketed in the US as Depo-Provera® or containing 104 mg DMPA and marketed as Depo-SubQ Provera 104®.
oral contraceptivesDrug
Oral contraceptives (any variety of formulations are permitted)
Implanon®Drug
Subdermal contraceptive implant, marketed in the US as Implanon® or Nexplanon® (containing 68 mg of etonogestrel)
ParaGard®Drug
Intrauterine device marketed in the US as ParaGard® (a T-shaped plastic device containing 380mm2 of copper surface)
Mirena®Drug
Intrauterine system, marketed in the US as Mirena® (containing 52 mg of levonorgestrel)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contraceptive Method DiscontinuationTime frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Planned Parenthood Central North Carolina
Chapel Hill, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.